植物纳米技术:一种用于阿尔茨海默病治疗的新型有益策略
Shayeri Chatterjee Ganguly1, Sk Sangram2, Sayani Paul3
1Department of Pharmaceutical Technology, Brainware University, West Bengal, India.
Neurochemistry international
|September 26, 2024
概括
植物成分在阿尔茨海默病 (AD) 治疗中表现有前途,但面临着交付挑战. 纳米技术提供了解决方案,以提高这些天然化合物的AD疗法的疗效.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特点是认知能力下降,神经元损失以及粉样β (Aβ) 斑块和团的积累.
- 植物成分,植物衍生化合物,由于其多样化的分子机制,被探索用于AD治疗.
- 植物成分的局限性包括血脑屏障 (BBB) 透率低,生物可用性低以及非目标效应.
研究的目的:
- 审查植物成分对阿尔茨海默病 (AD) 的治疗潜力.
- 讨论在AD治疗中使用植物成分的局限性.
- 突出基于纳米技术的策略来克服这些局限性并改善AD治疗.
主要方法:
- 文献综述侧重于植物成分和纳米技术在阿尔茨海默病研究中的应用.
- 对抗AD病理学的植物成分分子机制的分析.
- 检查纳米配方策略,以增强通过血脑屏障 (BBB) 的药物输送.
主要成果:
- 植物成分通过各种机制表现出对阿尔茨海默病的潜在治疗作用.
- 诸如不良的BBB透性和低生物可用性等挑战限制了植物成分的临床应用.
- 纳米配方显著提高了BBB透率,生物可用性和植物成分的向特异性.
结论:
- 植物成分和纳米技术的结合为阿尔茨海默病 (AD) 提供了一个有前途的治疗方法.
- 纳米配方策略可以有效地解决用于AD治疗的植物衍生化合物的交付挑战.
- 这种综合方法有可能彻底改变阿尔茨海默病 (AD) 治疗.
更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
11.9K
06:52Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
9.3K
相关概念视频
Alzheimer's Disease: Treatment
170
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451
siRNA - Small Interfering RNAs
16.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.6K
